BridgeMD
New treatment option for Tinnitus
Official title FR-taVNS Tinnitus Tria
ClinicalTrials.gov ID: NCT07711639
What this study is testing
- What it's testing
- Tinnitus is a common neurosensory symptom affecting 12-30% of adults and is closely associated with anxiety, sleep disturbance, and autonomic dysregulation. Current pharmacologic treatments offer limited efficacy and notable side effects, prompting interest in non-pharmacological approaches.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Age 18-75 years, conscious, able to communicate and comprehend, and able to complete questionnaires and comply with study procedures
- Tinnitus as the sole chief complaint, with pure-tone thresholds ≤25 dB HL bilaterally at 500, 1000, 2000, and 4000 Hz
You likely can't join if
- Objective tinnitus, peripheral vestibular disease, central nervous or cardiovascular causes, or other organic ear pathology
- Open wounds or skin lesions of the foot or ear, lower-limb edema, history of deep vein thrombosis, or diabetes with most recent HbA1c \>7.5%
- Cardiac pacemaker or other implanted electronic device, or other severe cardiovascular disease
- Foot reflexology or vagus nerve stimulation within the past 3 months
- Pregnant or breastfeeding women
- History of epilepsy or seizures
See the full eligibility criteria
- Age 18-75 years, conscious, able to communicate and comprehend, and able to complete questionnaires and comply with study procedures
- Tinnitus as the sole chief complaint, with pure-tone thresholds ≤25 dB HL bilaterally at 500, 1000, 2000, and 4000 Hz
- Objective tinnitus, peripheral vestibular disease, central nervous or cardiovascular causes, or other organic ear pathology
- Open wounds or skin lesions of the foot or ear, lower-limb edema, history of deep vein thrombosis, or diabetes with most recent HbA1c \>7.5%
- Cardiac pacemaker or other implanted electronic device, or other severe cardiovascular disease
- Foot reflexology or vagus nerve stimulation within the past 3 months
- Pregnant or breastfeeding women
- History of epilepsy or seizures
- Physically frail condition
The study team makes the final eligibility decision.
Where it's taking place
- Hualien City, Taiwan
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hualien City, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.